Chengdu, China

Long Li

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Ellipses Pharma Limited, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Long Li - Innovator in Pyrimidine Compounds

Introduction

Long Li is a notable inventor based in Chengdu, China. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on pyrimidine compounds. His research and inventions have the potential to impact various applications in medicine and pharmaceuticals.

Latest Patents

Long Li holds a patent for a salt and crystal form of a pyrimidine compound, along with the preparation methods for these forms. This patent specifically details a salt and a crystal form of a compound I, including a crystal form of the salt, and the methods for preparing them. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Throughout his career, Long Li has worked with prominent companies in the biopharmaceutical sector. Notably, he has been associated with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. and Ellipses Pharma Limited. His work in these organizations has allowed him to apply his innovative ideas and contribute to the advancement of biopharmaceutical research.

Collaborations

Long Li has collaborated with several professionals in his field, including Zheng Gong and Hongming Li. These collaborations have likely enriched his research and contributed to the successful development of his patented innovations.

Conclusion

Long Li is a distinguished inventor whose work on pyrimidine compounds has the potential to influence the biopharmaceutical industry significantly. His contributions, marked by his patent and collaborations, reflect his commitment to innovation and advancement in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…